With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma||Massachusetts General Hospital / Myron Ignatius, PhD||'A' Award Grants||2012||Massachusetts|
|The role of vitamin D in hepatoblastoma formation and prevention||Brigham and Women's Hospital / Wolfram Goessling, MD/PhD||Innovation Grants||2012||Massachusetts|
|Discovery of New Targets and Pathways for T-ALL Therapy||Dana-Farber Cancer Institute / Thomas Look||Bridge Grants||2012||Massachusetts|
|Selective inhibition of nuclear export as a novel therapeutic strategy in AML||Dana-Farber Cancer Institute / Julia Etchin||Young Investigator Grants||2012||Massachusetts|
|Development of the Next Generation FLT3 Inhibitors for Pediatric AML and Infant ALL||The Johns Hopkins University School of Medicine / Donald Small, MD, PhD||Innovation Grants||2012||Maryland|
|Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia||Washington University / Grant Challen, PhD||'A' Award Grants||2012||Missouri|
|Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research||Washington University / Kimberly Johnson Ph.D.||Epidemiology Grants||2012||Missouri|
|The role of NOTCH1 in T-cell acute lymphoblastic leukemia.||Columbia University Medical Center / Adolfo Ferrando||Bridge Grants||2012||New York|
|BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia||Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD||'A' Award Grants||2012||New York|
|Targeting Neovascularization in Graft-Versus-Host Disease||Memorial Sloan-Kettering Cancer Center / Marcel van den Brink, MD/PhD||Innovation Grants||2012||New York|